Literature DB >> 28655518

Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.

Na Liu1, Qi Zhou1, Yan-Hua Qi1, Hua Wang1, Li Yang2, Qing-Yu Fan3.   

Abstract

This study aims to explore the effects of long non-coding RNA H19 (lncRNA H19) and microRNA let7a (miRNA let7a) expression on the prognosis of thyroid cancer (TC). This may aid in the discovery of more effective treatment and prognosis approaches for TC. Between January 2008 and January 2011, 131 TC tissues and adjacent tissues were obtained from TC patients. An additional 122 normal thyroid tissues were also collected as normal controls from patients with benign thyroid lesions. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect lncRNA H19 and miRNA let7a mRNA expression. Five-year follow-ups were conducted. A Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic values of lncRNA H19 and miRNA let7a in TC. The Kaplan-Meier method was applied to analyze the 5-year survival rate of TC patients. Univariate and multivariate factor analyses were employed to analyze the prognostic factors of TC. The lncRNA H19 mRNA expression was higher while the miRNA let7a mRNA expression was lower in TC tissues than, in the normal thyroid tissues and adjacent tissues. The area under the ROC curve (AUC) of lncRNA H19 and miRNA let7a were 0.801 and 0.116, with sensitivity at 72.5% and 84%, as well as specificity 75.4% and 77%, respectively. In TC patients with tumor diameters≥1.0cm, lncRNA H19 mRNA expression was elevated, but miRNA let7a mRNA expression was reduced. This was also evident in TC patients with TNM stages III+IV and those with lymph node metastasis. TC patients with a lower 5-year survival rate showed upregulated levels of lncRNA H19 expression and, downregulated levels of miRNA let7a expression. LncRNA H19 and miRNA let7a expression, tumor diameter, TNM stage and lymph node metastasis were independent prognostic factors of TC. This study demonstrated that increased lncRNA H19 and decreased miRNA let7a expression levels are associated with poor prognosis in TC patients. An inverse relationship between lncRNA H19 and miRNA let7a expression levels was exhibited.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Long noncoding RNA H19; MicroRNA Let7a; Prognosis; Thyroid cancer

Mesh:

Substances:

Year:  2017        PMID: 28655518     DOI: 10.1016/j.yexmp.2017.06.004

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  13 in total

1.  LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.

Authors:  Meihua Liang; Jinliang Jia; Lili Chen; Biyue Wei; Qiang Guan; Zhaoming Ding; Jiawei Yu; Rui Pang; Guoqing He
Journal:  Endocrine       Date:  2019-04-27       Impact factor: 3.633

2.  Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway.

Authors:  Xiaoyu Li; Qinghuai Li; Xiao Jin; Hao Guo; Yong Li
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

3.  Long non-coding RNA DIO3OS/let-7d/NF-κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells.

Authors:  Mingming Wang; Jin Li; Zhongkun Zuo; Chutong Ren; Tenglong Tang; Chen Long; Yi Gong; Fei Ye; Zhihong Wang; Jiangsheng Huang
Journal:  J Cell Commun Signal       Date:  2020-10-15       Impact factor: 5.782

4.  Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor.

Authors:  Song Yang; Wanzhong Tang; Yuchao He; Linbao Wen; Bin Sun; Shengli Li
Journal:  Cell Death Dis       Date:  2018-01-24       Impact factor: 8.469

Review 5.  The Role of Long Non-Coding RNAs in Thyroid Cancer.

Authors:  Xuejiao Peng; Kun Zhang; Li Ma; Junfeng Xu; Weiqin Chang
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

6.  Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Authors:  Wei-Quan Liang; Chun-Fa Chen; Shu-Ming Sun; Xiao-Feng Lu; Chun-Yan Peng; Hao-Yu Lin
Journal:  Cancer Manag Res       Date:  2019-03-06       Impact factor: 3.989

Review 7.  Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in laryngeal squamous cell cancer.

Authors:  Yan Huang; Min Gu; Yiting Tang; Zhiqiang Sun; Judong Luo; Zhe Li
Journal:  Cancer Cell Int       Date:  2021-06-22       Impact factor: 5.722

8.  Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.

Authors:  Qiaowei Fan; Bingrong Liu
Journal:  Onco Targets Ther       Date:  2018-05-01       Impact factor: 4.147

9.  Diagnostic and prognostic values of blood microRNA-Let7A for osteosarcoma.

Authors:  Jun Hua; Dong Liu; Lumin Cao; Dengfeng Wang; Tao Wu; Fanguo Lin; Peng Su; Yanping Niu; Yongming Sun
Journal:  J Bone Oncol       Date:  2018-06-27       Impact factor: 4.072

10.  A Novel lncRNA Regulates the Toll-Like Receptor Signaling Pathway and Related Immune Function by Stabilizing FOS mRNA as a Competitive Endogenous RNA.

Authors:  Hao Fan; Zengpeng Lv; Liping Gan; Chao Ning; Zhui Li; Minghui Yang; Beibei Zhang; Bochen Song; Guang Li; Dazhi Tang; Jinxin Gao; Shaojia Yan; Youli Wang; Jianfeng Liu; Yuming Guo
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.